MedPath

The Extract of Green Tea on Obese Women: a Randomized Double Blindness Clinical Trial

Phase 3
Completed
Conditions
Obesity
Registration Number
NCT00383058
Lead Sponsor
Taipei City Hospital
Brief Summary

The purpose of this study is to examine whether the extract of the green tea is effective on obese women.

Detailed Description

We conducted the pilot study in 2005. The initial findings showed the extract of green tea is benefit on obese women. The potential benefit include appetite lowing, lipid markers decreasing and regulating balance of obese related hormone peptides. So we designed this trial.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  1. Age 16-60 years old female
  2. BMI>27㎞/m2
  3. Signed informed consent
Exclusion Criteria
  1. Endocrine disease, e.g. thyroid disorder, pituitary disorder, and sex gland disorder.
  2. Heart disease, e.g. arrhythmia, heart failure, myocardial infarction, and patient with pacemaker.
  3. Allergy and Immunology disease.
  4. High aminotransferases ( Alanine, Aspartate >80 IU/L) or high serum Creatinine (>2.5 mg/dL)
  5. Pregnant or lactating women.
  6. Childbirth within 6 months.
  7. Stroke or otherwise unable to exercise
  8. Management for weight control within 3 months.
  9. Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
(Percent) reduction of body mass index and body weight
Secondary Outcome Measures
NameTimeMethod
leptin, adiponectin and ghrelin comparisons and analysis
(Percent) reduction of: Glucose, cholesterol,LDL, HDL and triglyceride

Trial Locations

Locations (1)

Taipei Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath